AlphaImpactRx, Inc. provides primary research-based insights, analytics, and solutions to biopharmaceutical, consumer health, and medical device companies. The company offers BrandImpact, a solution provides insights into brand performance from the physician’s office; BrandImpact Global, a solution that provides insights into the drivers of global brand performance; BrandImpactDx, a solution that captures key information on testing rates and the types of tests used from the oncologists and pathologists using them; BrandImpactATU, a soluiotn that provides integrated insights into the underlying drivers of users brand performance; ProVoice, a solution that provides insights into consumer healt...
550 Blair Mill Road
Horsham, PA 19044
Founded in 2000
AlphaImpactRx Launches Brandimpact Global Diabetes
Jun 4 15
AlphaImpactRx, Inc. announced the launch of BrandImpact Global Diabetes and the expansion of its longitudinal mobile research model in the EU and Japan. AlphaImpactRx has extended BrandImpact's global reach through the creation of diabetes-focused physician research panels in France, Germany, Italy, Spain, UK and Japan. These new panels are in addition to the company's network of panels in the US as well as its core specialty panels currently operating in the EU, Canada and Australia. AlphaImpactRx's new disease-focused panels in the EU and Japan are designed to provide information tailored to the unique needs of diabetes brands competing in this dynamic, global market. BrandImpact Global Diabetes offers unique insight into both treatment behavior and the promotional factors influencing that behavior direct from the physician's practice setting and within a complete, competitive context. This near real-time insight enables diabetes brands to rapidly adjust to changes in market conditions, both locally and globally. Combined with its BrandImpact US primary care and endocrinology panels, AlphaImpactRx now offers its global clients research-based insight from more than 2,100 targeted diabetes health care professionals worldwide. The panels collect data on all classes within the diabetes market, including insulins, DPP-4's, GLP-1's, SGLT-2's, and their combinations, as well as blood glucose meters and infusion pumps. Additionally, BrandImpact's proprietary research app has been enhanced to capture key patient characteristics such as HbA1c, BMI and fasting plasma glucose levels which are important for understanding the drivers of brand choice for diabetic patients. Including the US, BrandImpact Global Diabetes is expected to capture information on more than 400,000 diagnosed diabetes patient visits and 150,000 diabetes brand details annually.
AlphaImpactRx Appoints Darrell Philpot as Senior Vice President, Analytics And Chief Methodologist
May 12 15
AlphaImpactRx announced that Darrell Philpot has joined the company as Senior Vice President, Analytics and Chief Methodologist. In this role, Mr. Philpot will lead the design and execution of AlphaImpactRx's data and analytics strategy, including the continued build-out of its analytic services team to reinforce the company's ability to deliver higher-level insight through targeted analytic offerings and solutions. Prior to joining AlphaImpactRx, Mr. Philpot was Group Director, Core Analytics at Adheris Health and a member of the company's extended executive leadership team.